SCHEMBL9584953

SCHEMBL9584953

COc1nc(N)nc2c1ncn2C(OCCCOC(=O)C(C)(C)C)OC(=O)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC20 Q12834 1/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ CDK1 P06493 3/20 0.33
▸ CDK2 P24941 3/20 0.33
▸ CCNB1 P14635 2/20 0.33
▸ CCNE1 P24864 2/20 0.33
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ABCB11 O95342 1/20 0.31
▸ POLA1 P09884 1/20 0.31
▸ POLG P54098 1/20 0.31
▸ FAP Q12884 1/20 0.31
▸ SLC22A6 Q4U2R8 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ CCNA2 P20248 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9583081 0.89 CDK1 (0.44) CDC20HDAC1HDAC2HDAC8CDK1
SCHEMBL9584007 0.85 HDAC1 (0.36) CDC20HDAC1HDAC2HDAC8HSP90AA1
SCHEMBL10818088 0.83 CDC20 (0.35) CDC20HDAC1HDAC2HDAC8HSP90AA1
SCHEMBL10817546 0.83 HDAC1 (0.36) CDC20HDAC1HDAC2HDAC8HSP90AA1
SCHEMBL9583124 0.82 KDM4E (0.41) HSP90AA1HSP90AB1POLBGAANPSR1
SCHEMBL9583423 0.81 HDAC1 (0.37) CDC20HDAC1HDAC2HDAC8HSP90AA1
SCHEMBL10848496 0.78 HDAC1 (0.38) CDC20HDAC1HDAC2HDAC8HSP90AA1
SCHEMBL9584895 0.77 HK1 (0.41) CDC20HDAC1HDAC2HDAC8CDK1
SCHEMBL9583770 0.75 ALDH1A1 (0.30) —
SCHEMBL10364403 0.75 ACHE (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback